Breast Metastatic Localization of Signet-Ring Cell Gastric Carcinoma von Parrell Soler, C., Palacios Marqués, A., Saco López, L., Bermejo De las Heras, R., Pertusa Martínez, S.

Volltext

Peritoneal Mullerian Tumor-Like (Endosalpingiosis-Leiomyomatosis Peritoneal) : A Hardly Known Entity von Bermejo De las Heras, R., Gómez, Alicia, Galiana, Nuria, Campos, Antonio, Puente, Rebeca, Bas, Ernesto, Díaz-Caneja, Carmen

Volltext

Breast metastatic localization of signet-ring cell gastric carcinoma von Parrell Soler, C, Palacios Marqués, A, Saco López, L, Bermejo De Las Heras, R, Pertusa Martínez, S

Volltext

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a... von Cescon, David W, Nowecki, Zbigniew, Gallardo, Carlos, Holgado, Esther, Iwata, Hiroji, Masuda, Norikazu, Otero, Marco Torregroza, Loi, Sherene, Guo, Zifang, Gonzalo, Gomez Abuin, Diego, Kaen, Matias, Molina, Stephen, Begbie, Philip, Clingan, Sherene, Loi, Dhanusha, Sabanathan, Donatienne, Taylor, Domicio Carvalho, Lacerda, Fernando Cezar Toniazzi, Lissa, Felipe, Silva, Joanne, Yu, Alejandro, Acevedo, Bohuslav, Melichar, Katarina, Petrakova, Jana, Prausova, Erik, Jakobsen, Jeanette, Jensen, Soren, Linnet, Tamas, Lorincz, Herve, Bonnefoi, Isabelle, Desmoulins, Jens-Uwe, Blohmer, Nadia, Harbeck, Jens, Huober, Christian, Kurbacher, Sibylle, Loibl, Tibor, Csoszi, Zsuzsanna, Kahan, Karoly, Mahr, John, Crown, Seamus, O'Reilly, Takaaki, Fujii, Hiroji, Iwata, Hirofumi, Mukai, Seigo, Nakamura, Shoichiro, Ohtani, Akihiko, Osaki, Yasuaki, Sagara, Masato, Takahashi, Koichiro, Tsugawa, Junichiro, Watanabe, Yutaka, Yamamoto, Teruo, Yamauchi, Angel, Gomez Villanueva, Alejandro, Juarez Ramiro, Flavia, Morales-Vasquez, David, Porter, Ewa, Chmielowska, Ewa, Nowakowska-Zajdel, Zbigniew, Nowecki, Barbara, Radecka, Joanna, Streb, Alexander, Arkhipov, Natalia, Fadeeva, Oleg, Lipatov, Kwong Hwa, Park, Yeon Hee, Park, Begona, Bermejo de las Heras, Javier, Cortes, Luis, de la Cruz Merino, Jose, Garcia Saenz, Maria, Gion, Mei-Ching, Liu, Chiun-Sheng, Huang, Cagatay, Arslan, Irfan, Cicin, Erhan, Gokmen, Ozgur, Ozyilkan, Sinan, Yavuz, Janine, Graham, Mark, Tuthill, Christopher, Twelves, Duncan, Wheatley, Oleksii, Kolesnik, Olena, Kolesnik, Alla, Nasonova, Olga, Ponomarova, Dmytro, Trukhin, Sibel, Blau, Madhu, Chaudhry, Scott, Cole, William, Irvin, Randa, Loutfi, Janice, Lu, Coral, Omene, Timothy, Panella, Michael, Schleider, Robert, Siegel, Michael, Simon, Frances, Valdes-Albini

Volltext

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer von Ross, L., Eisen, A., Elsafy, F., Fielding, A., Friedman, S., Gianni, L., Phillips, K.-A., Singer, C.F., Toi, M., Park, Y.H., Yang, H., Mailliez, A., Nagy, T., Sonke, G.S., Sun, Q., Colleoni, M.A., Kaufman, B., Cameron, D., Campbell, C., Sevelda, Paul, Öhler, Leopold, Rumpold, Holger, Rautenberg, Beate, Boadle, David, Mackey, John, Niraula, Saroj, Randal d’Hondt, Papadimitriou, Konstantinos, Lazzaro, Mauricio Fernández, Pilnik, Norma, Varela, Mirta, Darsow, Maren, Park-Simon, Tjoung-Won, Terhaag, Jürgen, Salat, Christoph, Dieterich, Max, García Sáenz, José Ángel, Lanza, Angels Arcusa, Quiroga, Vanesa, Jañez, Noelia Martínez, Crusades, Gema Llort, Rodríguez, César, Cretella, Elisabetta, Jegannathen, Apurna, Ishida, Kazushige, Watanabe, Junichiro, Takada, Masahiro, Nakamura, Seigo, Aogi, Kenjiro, Tsugawa, Koichiro, Seaward, Samantha A., Carney, Jennifer Fu, Bobolis, Kristie A., Eisenberg, Peter D., Hofstatter, Erin W., McCarron, Edward C., Herbolsheimer, Pia, Meisel, Jane L., Jones, Cheryl F., Spector, David M., Lo, Shelly S., Cristofanilli, Massimo, Hahn, Olwen M., Oliff, Ira A., Ansari, Bilal, Sharma, Priyanka, Armstrong, Deborah K., VanderWoude, Amy, Friday, Bret E.B., T, Benjamin, Kuzma, Charles S., Radford, James E., Soori, Gamini S., Vogel, Victor G., Wilkinson, Mary, Qamar, Rubina, Loman, Niklas, Silander, Gustav, Abreu, Miguel, Ciruelos Gil, Eva María, Bermejo de las Heras, Begoña, Busch, Steffi, Thomalla, Jörg, Altena, Renske, Chen, Shou-Tung, Huang, Chiun-Sheng, Yeh, Dah-Cherng, Pottier, Virginie, Yang, Hongjian, Fu, Peifen, Wang, Yongsheng, Fan, Zhimin, Landherr, László, Yerushalmi, Rinat, Conte, Pierfranco, Ciccarese, Mariangela, Mackiewicz, Jacek, Kalinka, Ewa, Im, Seock-Ah, Lee, Kyoung Eun

Volltext

A review of the combination among global change factors in forests, shrublands and pastures of the Mediterranean Region: Beyond drought effects von Doblas-Miranda, E., Alonso, R., Arnan, X., Bermejo, V., Brotons, L., de las Heras, J., Estiarte, M., Hódar, J.A., Llorens, P., Lloret, F., López-Serrano, F.R., Martínez-Vilalta, J., Moya, D., Peñuelas, J., Pino, J., Rodrigo, A., Roura-Pascual, N., Valladares, F., Vilà, M., Zamora, R., Retana, J.

Volltext

Addition of durvalumab (Dur) upon progression to bevacizumab (Bev) maintenance in advanced HER2-negative (HERNEG) breast cancer (BC): Safety, efficacy and biomarkers von Quintela-Fandino, M., Manso Sànchez, L.M., Holgado Martín, E., Moreno, M.C., Morales Murillo, S., Bermejo De Las Heras, B., Malon Gimenez, D., Colomer Bosch, R., Gonzalez Cortijo, L., Hornedo, J., Mouron, S., Muñoz, M., Escudero, S., Blanco, R., Mañes, S.

Volltext

14P Gut and oral microbiota profiling in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC) receiving pembrolizumab (P) plus eribulin (E): CALADRIO von Teng, N., Dalby, M.J., Kiu, R., Robinson, T., Gion Cortes, M., Bermejo De Las Heras, B., Perez Garcia, J.M., Calvo-Martinez, L., Prat, A., Marquez Vazquez, R., Ruiz Borrego, M., de la Cruz, S., Llombart Cussac, A., Curigliano, G., Schmid, P., Mancino, M., Hall, L., Robinson, S., Cortés, J., Malfettone, A.

Volltext

95P PAM50 HER2-enriched phenotype as a predictor of early response to neoadjuvant lapatinib plus trastuzumab HER2-positive breast cancer: Survival results of the SOLTI-PAMELA study von Pascual, T., Bermejo De Las Heras, B., Martinez, N., Oliveira, M., Pernas Simon, S., Lopez Lopez, R., Ruiz Cabrero, I., Alarcon, J.D., Martinez De Dueñas, E., Malon Gimenez, D., Gonzalez Cao, M., Manso Sanchez, L.M., Morales Murillo, S., Lopez de Ceballos, H., Cortés, J., Llombart Cussac, A., Prat, A.

Volltext

62P Outcomes of high-risk breast cancer (BC) patients from El Álamo IV registry and GEICAM adjuvant clinical trials von Martin Jimenez, M., Rodríguez-Lescure, A., Andres Conejero, R., Servitja Tormo, S., Anton Torres, A., Ruiz Borrego, M., Bermejo De Las Heras, B., Guerrero, A., Ramos Vazquez, M., Santaballa Bertran, A., Munoz, M., Batista, J.N., Lopez-Tarruella Cobo, S., Chacon Lopez-Muniz, J.I., Alvarez Lopez, I., Martinez del Prado, M.P., Miralles, J.J., Polonio, O., Jara Sanchez, C., Mori de Santiago, M.

Volltext

354TiP Unraveling trastuzumab emtansine resistance in HER2-positive advanced breast cancer: GEICAM KATIA study von Todo, F. Rojo, Stradella, A., García-Sáenz, J.A., De Las Heras, B. Bermejo, Romero, J.L. Alfonso, Barnadas, A., Peron, Y. Izarzugaza, Alba, E., López-Tarruella, S., Henao-Carrasco, F., Carrasco, E., Caballero, R., Del Campo, M.

Volltext

101P Predictors of 18F-fluorodeoxyglucose (F) positron-emission tomography (PET)-driven disease detection in patients (pts) with HER2[+] early breast cancer (EBC). A substudy of th... von Llombart Cussac, A., Prat, A., Pérez-García, J.M., Mateos, J., Pascual, T., Escrivà-De-Romani, S., Stradella, A., Ruiz-Borrego, M., Bermejo De Las Heras, B., Keyaerts, M., Sampayo-Cordero, M., Malfettone, A., Cortés, R., Galván, P., Cortés, J., Gebhart, G.

Volltext

Evaluation of pharmacodynamic (PD) and biologic activity in a preoperative window-of-opportunity (WOO) study of giredestrant (GDC-9545) in postmenopausal patients (pts) with estrog... von Moore, Heather M., Boni, Valentina, Bellet, Meritxell, Bermejo De Las Heras, Begoña, Gión Cortés, Maria, Oakman, Catherine, Schmid, Peter, Trinh, Xuan Bich, Wheatley, Duncan, Jhaveri, Komal L., Kabos, Peter, Lim, Elgene, Velu, Thierry, Metcalfe, Ciara, Gates, Mary R., Chang, Ching-Wei, Bond, John, Goldstein, Leonard D, Lauchle, Jennifer O'Hara, Bardia, Aditya

Volltext

Abstract OT3-02-05: CORALLEEN: A phase 2 clinical trial of chemotherapy or letrozole plus ribociclib as neoadjuvant treatment for postmenopausal patients with luminal B/HER2-negati... von Gavila, J, Saura, C, Oliveira, M, Ciruelos, E, Gonzalez, X, de la Peña, L, Bermejo de las Heras, B, Muñoz, M, Fernandez, P, Villagrasa, P, Ortega, V, Lopez, R, Celiz, P, Pascual, T, Prat, A

Volltext

Abstract PS11-05: Updated data from SERENA-1: A Phase 1 dose escalation and expansion study of the next generation oral SERD AZD9833 as a monotherapy and in combination with palboc... von Baird, Richard, Oliveira, Mafalda, Gil, Eva Maria Ciruelos, Patel, Manish R, Bermejo de las Heras, Begoña, Ruiz-Borrego, Manuel, García-Corbacho, Javier, Armstrong, Anne, Banerji, Udai, Twelves, Chris, Boni, Valentina, Incorvati, Jason, Kabos, Peter, Cohen, Adam L, de Paula, Bruno, Rodríguez, Marta Capelán, Wang, Judy S, Hernando, Christina, Gonzalez, Alejandro Falcón, Ruiz, Ivan Victoria, Lai-Kwon, Julia, Afghani, Anosheh, Vaklavas, Christos, Brier, Tim, Fox, Steven, Kirova, Bistra, Klinowska, Teresa, Leach, Chris, Lindemann, Justin PO, Mather, Richard, Maudsley, Rhiannon, Morrow, Christopher J, Sathiyayogan, Nitharsan, Sykes, Andy, Zhang, Li, Hamilton, Erika

Volltext

Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade von Brasó Maristany, Fara, Griguolo, Gaia, Pascual, Tomás, Paré, Laia, Nuciforo, Paolo, Llombart Cussac, Antonio, Bermejo de las Heras, Begoña, Oliveira, Mafalda, Morales, Serafín, Martínez, Noelia, Vidal Losada, Maria Jesús, Adamo, Barbara, Martínez, Olga, Pernas, Sònia, López, Rafael, Muñoz Mateu, Montserrat, Chic Ruché, Núria, Galván, Patricia, Garau, Isabel, Manso, Luis, Alarcón, Jesús, Martínez, Eduardo, Gregorio, Sara, Gomis, Roger R, Villagrasa, Patricia, Cortés, Javier, Ciruelos, Eva, Prat Aparicio, Aleix

Volltext

72OAddition of durvalumab (Dur) upon progression to bevacizumab (Bev) maintenance in advanced HER2-negative (HERNEG) breast cancer (BC): Safety, efficacy and biomarkers von Quintela-Fandino, M, Manso Sànchez, L M, Holgado Martín, E, Moreno, M C, Morales Murillo, S, Bermejo De Las Heras, B, Malon Gimenez, D, Colomer Bosch, R, Gonzalez Cortijo, L, Hornedo, J, Mouron, S, Muñoz, M, Escudero, S, Blanco, R, Mañes, S

Volltext

Prevalence and European comparison of dementia in a ≥75-year-old composite population in Spain von Virués-Ortega, J., de Pedro-Cuesta, J., Vega, S., Seijo-Martínez, M., Saz, P., Rodríguez, F., Rodríguez-Laso, Á., Reñé, R., de las Heras, S. P., Mateos, R., Martínez-Martín, P., Mahillo-Fernández, I., López-Pousa, S., Lobo, A., Reglà, J. L., Gascón, J., García, F. J., Fernández-Martínez, M., Boix, R., Bermejo-Pareja, F., Bergareche, A., Sánchez-Sánchez, F., de Arce, A., del Barrio, J. L.

Volltext

Tumor-infiltrating lymphocytes (TILs) in HER2-positive (HER2+) early breast cancer treated with neoadjuvant lapatinib and trastuzumab without chemotherapy in the PAMELA Trial von Nuciforo, P., Prat, A., Llombart, A., Fasani, R., Paré, L., Pascual, T., Oliveira, M., Martínez Jañez, N., Bermejo De Las Heras, B., Vidal, M., Pernas Simon, S., López, R., Muñoz, M., Garau, I., Manso, L., Alarcon Company, J., Martinez de Dueñas, E., Villagrasa Gonzalez, P., Cortes Castan, J., Holgado, E.

Volltext

Effects of furocoumarins from Cachrys trifida on some macrophage functions von Abad, M. J., de las Heras, B., Silván, A. M., Pascual, R., Bermejo, P., Rodriguez, B., Villar, A. M.

Volltext